Buchang Pharma's Subsidiary to Set Up Joint Venture

MT Newswires Live
06/10

Shandong Buchang Pharmaceuticals' (SHA:603858) subsidiary, Shanghai Hepu Medical Technology, agreed to established a joint venture with Sichuan Lindong Enterprise Management Center (Limited Partnership), according to Shanghai bourse filing on Wednesday.

The joint venture company, Sichuan Hepu Tongchuang Medical Technology, will have a registered capital of 4.5 million yuan

Hepu Medical Tech will own 70% of the venture after investing 3.2 million yuan, while Sichuan Lindong will own the remaining 30% after investing 1.4 million yuan.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10